Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

RITA

🥰Excellent
Catalog No. T1798Cas No. 213261-59-7
Alias RITA (NSC 652287), NSC 652287

RITA (NSC-652287)(NSC-652287) induced cross-links of both DNA-DNA and DNA-protein with no detectable DNA single-strand breaks. RITA, like nutlin-3, can disrupt the p53/Mdm2 interaction.

RITA

RITA

🥰Excellent
Purity: 98.85%
Catalog No. T1798Alias RITA (NSC 652287), NSC 652287Cas No. 213261-59-7
RITA (NSC-652287)(NSC-652287) induced cross-links of both DNA-DNA and DNA-protein with no detectable DNA single-strand breaks. RITA, like nutlin-3, can disrupt the p53/Mdm2 interaction.
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
2 mg$38In Stock
5 mg$61In Stock
10 mg$97In Stock
25 mg$198In Stock
50 mg$363In Stock
100 mg$535In Stock
200 mg$752In Stock
500 mg$1,150In Stock
1 mL x 10 mM (in DMSO)$82In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "RITA"

Select Batch
Purity:98.85%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
RITA (NSC-652287)(NSC-652287) induced cross-links of both DNA-DNA and DNA-protein with no detectable DNA single-strand breaks. RITA, like nutlin-3, can disrupt the p53/Mdm2 interaction.
Targets&IC50
p53dN:1.5 nM (Kd)
In vitro
RITA (10 nM) caused cell cycle arrest and accumulation of cells in the G2-M phase, and at 100 nM it induced DNA fragmentation and apoptosis and increased p53 protein levels. RITA (30 nM) also induced the production of DNA-protein and DNA-DNA crosslinks in A498 cells. At the same time, RITA did not affect top1-regulated superhelical SV40 DNA loosening. RITA significantly inhibited HCT116 cell growth (97%) and slightly inhibited HCT116 TP53-/- cell growth (13%). RITA inhibited the growth of wild-type p53-expressing cells more effectively than that of cells lacking p53 or with p53 mutation. When acting on tumor cells, RITA showed a high degree of selectivity for different toxicities due to the accumulation of cytoplasmic (S100) fractions.RITA bound to full-length p53 but not to glutathione S-transferase proteins or HDM-2.RITA also inhibited the growth of other renal cell lines including ACHN and UO-31 (IC50: 13 μM and 37 μM). RITA blocked p53-HDM-2 interaction and p53 ubiquitination.RITA caused a significant decrease in the amount of HDM-2 co-precipitated with p53, although both proteins were up-regulated.RITA blocked the interaction between 6XHis-tagged His-HDM-2 protein and purified GST-p53. By promoting p53Ser46 phosphorylation, RITA induces apoptosis. RITA induced p53 activation and showed upregulation of phosphorylated MKK-4, ASK-1 and c-Jun. It also induced JNK signaling activation. NMR results showed that RITA did not block the formation of the complex between the N-terminal p53-binding domain (residues 1-118) and p53 (residues 1-312) of MDM2, which may be related to the fact that the binding of RITA requires the natural conformation of p53.
In vivo
RITA (10 nM) caused cell cycle arrest and accumulation of cells in the G2-M phase, and at 100 nM it induced DNA fragmentation and apoptosis and increased p53 protein levels. RITA (30 nM) also induced the production of DNA-protein and DNA-DNA crosslinks in A498 cells. At the same time, RITA did not affect top1-regulated superhelical SV40 DNA loosening. RITA significantly inhibited HCT116 cell growth (97%) and slightly inhibited HCT116 TP53-/- cell growth (13%). RITA inhibited the growth of wild-type p53-expressing cells more effectively than that of cells lacking p53 or with p53 mutation. When acting on tumor cells, RITA showed a high degree of selectivity for different toxicities due to the accumulation of cytoplasmic (S100) fractions.RITA bound to full-length p53 but not to glutathione S-transferase proteins or HDM-2.RITA also inhibited the growth of other renal cell lines including ACHN and UO-31 (IC50: 13 μM and 37 μM). RITA blocked p53-HDM-2 interaction and p53 ubiquitination.RITA caused a significant decrease in the amount of HDM-2 co-precipitated with p53, although both proteins were up-regulated.RITA blocked the interaction between 6XHis-tagged His-HDM-2 protein and purified GST-p53. By promoting p53Ser46 phosphorylation, RITA induces apoptosis. RITA induced p53 activation and showed upregulation of phosphorylated MKK-4, ASK-1 and c-Jun. It also induced JNK signaling activation. NMR results showed that RITA did not block the formation of the complex between the N-terminal p53-binding domain (residues 1-118) and p53 (residues 1-312) of MDM2, which may be related to the fact that the binding of RITA requires the natural conformation of p53.
Kinase Assay
The inhibition profile of cabozantinib against a broad panel of 270 human kinases is determined using luciferase-coupled chemiluminescence,?33P-phosphoryl transfer, or AlphaScreen technology. Recombinant human full-length, glutathione?S-transferase tag, or histidine tag fusion proteins are used, and half maximal inhibitory concentration (IC50) values are determined by measuring phosphorylation of peptide substrate poly (Glu, Tyr) at ATP concentrations at or below the?Km?for each respective kinase. The mechanism of kinase inhibition is evaluated using the AlphaScreen Assay by determining the IC50?values over a range of ATP concentrations.
Cell Research
Examination to assess susceptibility of cells to RITA (0.1 nM - 1 mM) is done using the XTT assay. Cells are inoculated into 96-well flat-bottom plates at a density of 1500 cells per well and incubated for 24 hours at 37 °C in a humidified 5% CO2 5% air atmosphere. Serial concentrations of RITA in DMSO are added to the wells, and sensitivity is determined 48 hours after the addition of RIT(Only for Reference)
AliasRITA (NSC 652287), NSC 652287
Chemical Properties
Molecular Weight292.37
FormulaC14H12O3S2
Cas No.213261-59-7
SmilesOCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1
Relative Density.1.396 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (153.91 mM)
Ethanol: 7.3 mg/mL (25 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM3.4203 mL17.1016 mL34.2032 mL171.0162 mL
5 mM0.6841 mL3.4203 mL6.8406 mL34.2032 mL
10 mM0.3420 mL1.7102 mL3.4203 mL17.1016 mL
20 mM0.1710 mL0.8551 mL1.7102 mL8.5508 mL
DMSO
1mg5mg10mg50mg
50 mM0.0684 mL0.3420 mL0.6841 mL3.4203 mL
100 mM0.0342 mL0.1710 mL0.3420 mL1.7102 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy RITA | purchase RITA | RITA cost | order RITA | RITA chemical structure | RITA in vivo | RITA in vitro | RITA formula | RITA molecular weight